Literature DB >> 11357476

Glucose and other insulin secretagogues induce, rather than inhibit, expression of Id-1 and Id-3 in pancreatic islet beta cells.

B M Wice1, E Bernal-Mizrachi, M A Permutt.   

Abstract

AIMS/HYPOTHESIS: Basic helix loop helix transcription factors regulate insulin gene transcription. Therefore, molecules that regulate their function should affect insulin production and secretion. As Id proteins inhibit basic helix loop helix function, it is important to determine whether they are expressed in beta cells and if insulin secretagogues regulate their expression.
METHODS: Human islets or insulinoma cells were cultured in different glucose concentrations or treated with secretagogues. Insulin secretion was measured using RIA. The Id mRNA and protein concentrations were measured using northern blots, RT-PCR, and western blots. Transfections of promoter-reporter constructs were used to estimate Id-1 gene transcription.
RESULTS: The Id-1 mRNA concentrations were twofold higher in islets cultured overnight in 10 mmol/l than in 2.5 mmol/l glucose. Addition of high glucose to islets previously cultured in low glucose, increased Id-1 mRNA concentrations within 30 min. Analyses using insulinoma cells revealed that Id-1 and Id-3 mRNA concentrations peaked 30 min after glucose was added, returned to near basal concentrations by 2 h and then progressively increased for 24 h. The Id-1 protein concentrations changed in a similar pattern. Insulin secretagogues that act through different signaling pathways also induced Id expression. The Id response required glucose metabolism, calcium, and RNA synthesis but not protein synthesis. Glucose-responsive elements are confined to the 5'-region of the Id-1 gene. CONCLUSION/
INTERPRETATION: The concomitant induction of Id-1 and Id-3 expression, insulin gene transcription, and insulin secretion suggests that physiological concentrations of Ids do not inhibit insulin gene transcription and Ids could play unexpected and novel roles in promoting beta-cell function.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11357476     DOI: 10.1007/s001250051643

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  9 in total

1.  Xenin-25 potentiates glucose-dependent insulinotropic polypeptide action via a novel cholinergic relay mechanism.

Authors:  Burton M Wice; Songyan Wang; Dan L Crimmins; Kelly A Diggs-Andrews; Matthew C Althage; Eric L Ford; Hung Tran; Matthew Ohlendorf; Terry A Griest; Qiuling Wang; Simon J Fisher; Jack H Ladenson; Kenneth S Polonsky
Journal:  J Biol Chem       Date:  2010-04-26       Impact factor: 5.157

2.  Inhibitor of differentiation proteins protect against oxidative stress by regulating the antioxidant-mitochondrial response in mouse beta cells.

Authors:  Mohammed Bensellam; Magdalene K Montgomery; Jude Luzuriaga; Jeng Yie Chan; D Ross Laybutt
Journal:  Diabetologia       Date:  2015-01-31       Impact factor: 10.122

3.  Id3 upregulates BrdU incorporation associated with a DNA damage response, not replication, in human pancreatic β-cells.

Authors:  Seung-Hee Lee; Ergeng Hao; Fred Levine; Pamela Itkin-Ansari
Journal:  Islets       Date:  2011-11-01       Impact factor: 2.694

Review 4.  Recent Insights Into Mechanisms of β-Cell Lipo- and Glucolipotoxicity in Type 2 Diabetes.

Authors:  Maria Lytrivi; Anne-Laure Castell; Vincent Poitout; Miriam Cnop
Journal:  J Mol Biol       Date:  2019-10-16       Impact factor: 5.469

Review 5.  E Proteins and ID Proteins: Helix-Loop-Helix Partners in Development and Disease.

Authors:  Lan-Hsin Wang; Nicholas E Baker
Journal:  Dev Cell       Date:  2015-11-09       Impact factor: 12.270

6.  ID'ing a novel inhibitor of β-cell function, Id1.

Authors:  Nils Billestrup
Journal:  Diabetes       Date:  2011-10       Impact factor: 9.461

7.  Inhibition of Id1 augments insulin secretion and protects against high-fat diet-induced glucose intolerance.

Authors:  Mia C Akerfeldt; D Ross Laybutt
Journal:  Diabetes       Date:  2011-09-22       Impact factor: 9.461

Review 8.  Contribution of Inhibitor of DNA Binding/Differentiation-3 and Endocrine Disrupting Chemicals to Pathophysiological Aspects of Chronic Disease.

Authors:  Vincent Avecilla; Mayur Doke; Quentin Felty
Journal:  Biomed Res Int       Date:  2017-07-13       Impact factor: 3.411

9.  PCB153-induced overexpression of ID3 contributes to the development of microvascular lesions.

Authors:  Jayanta K Das; Quentin Felty
Journal:  PLoS One       Date:  2014-08-04       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.